Early safety check: how two experimental drugs mix in the body
NCT ID NCT07425899
Summary
This early-stage study aims to understand how two drugs, ABBV-722 and upadacitinib, interact when taken together by healthy adults. It will measure the levels of each drug in the blood and check for side effects. The goal is to gather basic safety data to inform future research, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Acpru /Id# 279285
Grayslake, Illinois, 60030, United States
Conditions
Explore the condition pages connected to this study.